Perceptive Advisors’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

Perceptive Advisors’s Portfolio GRTX Stock Details GRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-254,664	Closed	-$2.5M	–	161
2021 Q2	$2.5M	Hold	254,664	–	–	0.03%	135
2021 Q1	$2.25M	Sell	254,664 -70,336	-22%	-$772K	0.03%	125
2020 Q4	$3.33M	Hold	325,000	–	–	0.04%	128
2020 Q3	$2.94M	Hold	325,000	–	–	0.04%	111
2020 Q2	$2.32M	Hold	325,000	–	–	0.04%	103
2020 Q1	$3.09M	Hold	325,000	–	–	0.08%	85
2019 Q4	$4.28M	Buy	+325,000	New	+$3.96M	0.09%	82

Other funds holding GRTX

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

NFGH

Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors's GRTX Position: Q3 2021 in Review

Perceptive Advisors sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q3 2021, closing a stake of 254,664 shares — an estimated $2.5M sold.

Perceptive Advisors first reported a position in GRTX in Q4 2019 and held it in 7 quarters. The position peaked at $4.28M in Q4 2019. 40 funds tracked by Wall St. Rank hold GRTX as of Q3 2021.

Perceptive Advisors reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Perceptive Advisors sold 254,664 Galera Therapeutics, Inc. Common Stock shares in Q3 2021, an estimated $2.5M.
Perceptive Advisors first reported a position in Galera Therapeutics, Inc. Common Stock in Q4 2019 and held it in 7 quarters.
Perceptive Advisors's Galera Therapeutics, Inc. Common Stock position peaked at $4.28M in Q4 2019.
40 funds tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q3 2021.

Based on Perceptive Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.